Response to the letter from Marc B Stone, MD; Tarek A Hammad, MD, PhD, MSc, MS

Journal of Psychiatric Research

Volumn 48, Issue 1, 2014, Pages 133-134

  Garlow, Steven J ^a  

^a EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Antidepressant; Minor depression; Suicide

Indexed keywords

FLUOXETINE;

AGE DISTRIBUTION; DEPRESSION; DRUG EXPOSURE; FOOD AND DRUG ADMINISTRATION; GENERAL CONDITION DETERIORATION; HUMAN; LETTER; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; PUBLICATION; RISK; SUICIDAL IDEATION;

ANTIDEPRESSANT; MINOR DEPRESSION; SUICIDE;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; HUMANS; MALE; SUICIDAL IDEATION;

EID: 84888440792     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.09.011     Document Type: Letter

References (6)

1. Dasgupta K. Additional cases of suicidal ideation associated with fluoxetine. Am J Psychiatry 1990, 147(11):1570.
2. Garlow S.J., Kinkead B., Thase M.E., Judd L.L., Rush A.J., Yonkers K.A., et al. Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder. J Psychiatric Res 2013, 47:1199-1203.
3. Hoover C.E. Additional cases of suicidal ideation associated with fluoxetine.". Am J Psychiatry 1990, 147(11):1570-1571.
4. Masand P., Gupta S., Dewan M. Suicidal ideation related to fluoxetine treatment. NEJM 1991, 324(6):420.
5. Stone M., Laughren T., Jones M.L., Levenson M., Holland P.C., Hughes A., et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ 2007, 339(b2880).
6. Teicher M.H., Glod C., Cole J.O. Emergence of intense suicidal preoccupation during treatment fluoxetine treatment. Am J Psychiatry 1990, 147(2):207-210.